| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/24/2011 | WO2011034362A2 Composition containing saururus chinensis extract or sauchinone as an active ingredient, for preventing and treating diseases caused by the overexpression of lxr-α |
| 03/24/2011 | WO2011034225A1 Composition for preventing or treating liver toxicity, including arrowroot extract or a fermented arrowroot extract/lactobacillus compound as an active ingredient |
| 03/24/2011 | WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
| 03/24/2011 | WO2011034131A1 Agent for the prevention or treatment of inflammatory bowel disease |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011034039A1 Eradicating agent and eradication method for helicobacter pylori |
| 03/24/2011 | WO2011033310A1 Encapsulated intestinal flora extracted from feces for use in the treatment of gastrointestinal disorders |
| 03/24/2011 | WO2011032981A1 Use of arc for inhibiting cell death during liver failure |
| 03/24/2011 | WO2011032233A1 Novel omega conotoxin peptides |
| 03/24/2011 | WO2011007347A3 Therapy of non alcoholic fatty liver disease utilizing inula viscosa extract |
| 03/24/2011 | WO2010108001A3 Agents and methods for tissue repair and regeneration |
| 03/24/2011 | WO2010052467A3 Canine oral cavity probiotics |
| 03/24/2011 | US20110071612 Anti-angiogenic compositions and methods of use |
| 03/24/2011 | US20110071217 Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes |
| 03/24/2011 | US20110071211 MicroRNA (miRNA) And Downstream Targets For Diagnostic And Therapeutic Purposes |
| 03/24/2011 | US20110071208 Lipid encapsulated dicer-substrate interfering rna |
| 03/24/2011 | US20110071202 Anti-hepatitis c virus agents and anti-hiv agents |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |
| 03/24/2011 | US20110071196 Compounds Which Selectively Modulate The CB2 Receptor |
| 03/24/2011 | US20110071184 Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder |
| 03/24/2011 | US20110071175 Indoles and Their Therapeutic Use |
| 03/24/2011 | US20110071163 Use of an opioid receptor antagonist for the treatment or prevention of gastrointestinal tract disorders |
| 03/24/2011 | US20110071162 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071161 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2011 | US20110071154 Pyrrolidin-3-ylmethyl-amine as orexin antagonists |
| 03/24/2011 | US20110071152 5-membered heterocycle-based p38 kinase inhibitors |
| 03/24/2011 | US20110071149 Selective kinase inhibitors |
| 03/24/2011 | US20110071145 Raf Modulators And Methods Of Use |
| 03/24/2011 | US20110071142 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases |
| 03/24/2011 | US20110071134 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| 03/24/2011 | US20110071132 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof |
| 03/24/2011 | US20110071131 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands |
| 03/24/2011 | US20110071129 Spirodiamine-diaryl ketoxime derivative |
| 03/24/2011 | US20110071127 Compounds Which Modulate the CB2 Receptor |
| 03/24/2011 | US20110071106 Glycosaminoglycan oral use and compositions |
| 03/24/2011 | US20110071103 Methods of treating hepatic encephalopathy |
| 03/24/2011 | US20110071095 Compositions and Methods for Increasing Telomerase Activity |
| 03/24/2011 | US20110071077 Thrombopoietic Compounds |
| 03/24/2011 | US20110071075 Promoter for bicarbonate secretion in gastrointestinal tract |
| 03/24/2011 | US20110070320 Biodegradable thermoresponsive 3-arm polyethylene glycol poly(lactide-co-glycolide) copolymer for ginseng administration |
| 03/24/2011 | US20110070281 Reparative cell delivery via hyaluronic acid vehicles |
| 03/24/2011 | US20110070270 Immunostimulating agent |
| 03/24/2011 | US20110070237 Methods of modulating and identifying agents that modulate intracellular calcium |
| 03/24/2011 | US20110070236 Use of immunesuppressant receptor |
| 03/24/2011 | US20110070196 Hepatitis c virus inhibitors |
| 03/24/2011 | DE102009041048A1 Topically applicable pharmaceutical composition, useful for treating skin diseases e.g. actinic keratosis, comprises a frankincense extract or a frankincense active material and hyaluronic acid or its derivatives |
| 03/24/2011 | CA2774357A1 Compositions and methods for treating disorders of gastrointestinal motility |
| 03/24/2011 | CA2774269A1 Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency |
| 03/24/2011 | CA2774021A1 Use of opioid receptor antagonist for gastrointestinal tract disorders |
| 03/24/2011 | CA2773125A1 Compounds having tafia inhibitory activity |
| 03/24/2011 | CA2772968A1 Advantageous mu-opiate receptor peptide compounds |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298801A1 Glycosylated glp-1 peptide |
| 03/23/2011 | EP2298793A2 Polypeptide fragments of hepatitis E virus, vaccine composition comprising said fragments and diagnostic kits |
| 03/23/2011 | EP2298772A1 Fused heterocyclic compounds |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298354A2 Remodelling and glycoconjugation of interferon-beta |
| 03/23/2011 | EP2298348A1 Antibody binding alpha4Beta7 integrin and its use to treat inflammatory bowel disease |
| 03/23/2011 | EP2298314A1 Dosage unit comprising a prostaglandin analog for treating constipation |
| 03/23/2011 | EP2298313A1 Pharmaceutical composition for external application containing prochlorperazine |
| 03/23/2011 | EP2298308A2 Integrin-binding small molecules |
| 03/23/2011 | EP2298301A2 Medicaments for increasing endogenous Erythropoietin (EPO) |
| 03/23/2011 | EP2298300A1 Compositions for inhibition of anglogenesis comprising thalidomide and aspirin |
| 03/23/2011 | EP2298298A2 Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors |
| 03/23/2011 | EP2298284A2 Mucoadhesive pharmaceutical formulations |
| 03/23/2011 | EP2298283A2 Pharmaceutical formulations comprising cannabinoids |
| 03/23/2011 | EP2297164A1 Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 03/23/2011 | EP2297163A1 Pyrazolospiroketone acetyl-c0a carboxylase inhibitors |
| 03/23/2011 | EP2297143A1 Substituted aminothiazole prodrugs of compounds with anti-hcv activity |
| 03/23/2011 | EP2297137A1 Novel heteroaryl carboxamide derivatives |
| 03/23/2011 | EP2296683A2 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
| 03/23/2011 | EP2296677A1 Pro biotic foodstuff and/or drinking water adjunct and use thereof |
| 03/23/2011 | EP2296670A1 Glycosaminoglycan oral use and compositions |
| 03/23/2011 | EP2296649A1 Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 03/23/2011 | EP2296612A1 Therapeutic and prophylactic formulation for oral care |
| 03/23/2011 | EP2296470A2 Compositions and methods for inhibiting gastric acid secretion |
| 03/23/2011 | EP2195314B1 Disubstituted alkyl-8-azabicyclo [3.2.1.]octane compounds as mu opioid receptor antagonists |
| 03/23/2011 | EP1631305B1 Sincalide formulations |
| 03/23/2011 | EP1552462B1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 03/23/2011 | EP1448205B1 Combinations for the treatment of immunoinflammatory disorders |
| 03/23/2011 | EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/23/2011 | CN1990032B Composite intravenous injection emulsion of glossy ganoderma spore oil and coix seed oil and method for making same |
| 03/23/2011 | CN1814177B Chinese medicine composition for treating digestive ulcer and its preparation method |
| 03/23/2011 | CN1785249B Novel use of medicine composition containing red-rooted salvia |
| 03/23/2011 | CN101990533A Novel salt of tegaserod |
| 03/23/2011 | CN101990450A Use of lipid-rich nutrition for the treatment of post-operative ileus |
| 03/23/2011 | CN101988071A Hepatitis c virus vaccine |
| 03/23/2011 | CN101987863A Oleanolic acid piperazine salt and preparation method thereof |
| 03/23/2011 | CN101987195A Reduced glutathione medicine absorbed through oral mucosa |
| 03/23/2011 | CN101987193A Traditional Chinese medicine preparation for treating cholecystitis and cholelithiasis |
| 03/23/2011 | CN101987192A Traditional Chinese medicine composition for protecting liver, preparation method and quality control method thereof |
| 03/23/2011 | CN101987175A Traditional Chinese medicine for treating diabetic gastroplegia |
| 03/23/2011 | CN101987172A Antidiarrheic Chinese medicine and preparation method thereof |
| 03/23/2011 | CN101987169A Composition comprising an extract of herbal combination thereof for preventing and treating diabetes mellitus |
| 03/23/2011 | CN101987167A Medicine with cathartic function |
| 03/23/2011 | CN101987164A Traditional Chinese medicine for treating diabetic diarrhea |
| 03/23/2011 | CN101987156A Medicine for treating toothache and preparation method thereof |
| 03/23/2011 | CN101987142A Active ingredient detection method of traditional Chinese medicine soft capsule |
| 03/23/2011 | CN101987141A New application of Pu'er tea and preparation for preventing and treating dental fluorosis |